reiterateVZfinnhub
Barclays Reiterates Equal-Weight Rating on Verizon Communications Inc. (VZ)
Barclays reiterated its Equal-Weight rating on Verizon Communications Inc. (NYSE:VZ) on October 27, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Barclays reiterated its Equal-Weight rating on Verizon Communications Inc. (NYSE:VZ) on October 27, 2026.
Read moreTD Cowen reiterated its Buy rating on Verizon Communications Inc. (NYSE:VZ) on October 27, 2026.
Read moreWedbush reiterated its Neutral rating on Intel Corporation (NASDAQ:INTC) on October 27, 2026.
Read moreRosenblatt reiterated its Sell rating on Intel Corporation (NASDAQ:INTC) on October 27, 2026.
Read moreB of A Securities reiterated its Buy rating on The TJX Companies, Inc. (NYSE:TJX) on October 27, 2026.
Read moreArgus Research analysts downgraded Abbott Laboratories (NYSE:ABT) from Buy to Hold on October 27, 2026.
Read moreCitigroup reiterated its Neutral rating on American Express Company (NYSE:AXP) on October 27, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on UNITEDHEALTH GROUP INCORPORATED (Delaware) (NYSE:UNH) on October 27, 2026.
Read moreWells Fargo reiterated its Overweight rating on UNITEDHEALTH GROUP INCORPORATED (Delaware) (NYSE:UNH) on October 27, 2026.
Read moreRosenblatt reiterated its Buy rating on Palantir Technologies Inc. (NASDAQ:PLTR) on October 27, 2026.
Read moreDA Davidson analysts upgraded Broadcom Inc. (NASDAQ:AVGO) from Neutral to Buy on October 27, 2026.
Read moreRosenblatt reiterated its Buy rating on Broadcom Inc. (NASDAQ:AVGO) on October 27, 2026.
Read moreWedbush reiterated its Outperform rating on ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) on October 27, 2026.
Read moreWells Fargo reiterated its Overweight rating on Xencor, Inc. (NASDAQ:XNCR) on October 27, 2026.
Read moreWedbush reiterated its Outperform rating on Xencor, Inc. (NASDAQ:XNCR) on October 27, 2026.
Read moreRBC Capital reiterated its Outperform rating on Xencor, Inc. (NASDAQ:XNCR) on October 27, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Custom Truck One Source, Inc. (NYSE:CTOS) on October 27, 2026.
Read moreRoth Capital analysts initiated coverage on Dianthus Therapeutics, Inc. (NASDAQ:DNTH) with a rating of Buy on October 27, 2026.
Read morePiper Sandler reiterated its Overweight rating on Agilysys, Inc. (NASDAQ:AGYS) on October 27, 2026.
Read moreNeedham reiterated its Buy rating on Agilysys, Inc. (NASDAQ:AGYS) on October 27, 2026.
Read more